IP Library Granted Patent US 11,452,835
Granted Patent B2
US 11,452,835 · App. 16/665,353 · Granted Sep 27, 2022

Apparatus and method for humidity conditioning sample gas of a patient breathing circuit affiliated with a ventilator and/or nitric oxide delivery system

Inventors: John P. Stanton (Madison, WI); John V. Berndt (Oregon, WI)
Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
A61M16/1005A61B5/097A61K33/00A61M16/085A61M16/12A61M16/16B01D53/268B01D71/36G01N33/0011G01N33/0036G01N33/15A61M16/14A61M16/202A61M2016/0039A61M2016/102A61M2016/1035A61M2202/0275A61M2205/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,452,835
App. No.
16/665,353
Granted
Sep 27, 2022
Kind
B2
Abstract

A therapeutic gas is administered to a patient. A sample gas is drawn from the therapeutic gas supply, and passed through a water-permeable tubular membrane. Concurrently, a section of the water permeable tubular membrane is maintained as a ventilated water permeable tubular membrane, by exposing outer surfaces of the ventilated water permeable tubular membrane to an ambient air flow. The ambient air flow may in some examples be moved over the tubular membrane via forced air such as for example via a fan associated with a housing surrounding the tubular membrane.

Claims (34)

1. A sample gas conditioning apparatus, comprising:

a housing, at least partially defining a chamber, and at least partially defining an air input path into the chamber and an air egress path from the chamber, the housing comprising:

an annular end plate comprising:

an inner perimeter edge that is spaced from and circumferential around a winding axis;

an outer perimeter edge; and

a winding support extending from the inner perimeter edge, a support length toward a housing open end; and

housing side walls that extend from the outer a peripheral rim region to the housing open end, in a direction parallel to the winding axis;

a fan, connected to the housing, configured to urge an ambient air flow through the chamber, the ambient air flow entering through the air input path into the chamber, and exiting the chamber through the air egress path;

a sample gas tube having a coiled tube section that comprises a water permeable material, at least a portion of the coiled tube section being arranged in the chamber as a ventilated section, the ventilated section being ventilated by the ambient air flow through the chamber, wherein the coiled tube section comprises a coil winding around the winding axis and the winding support,

wherein the fan, the air input path, the air egress path, and the housing have a joint configuration that urge the ambient air flow through the chamber to have a flow direction, the flow direction being generally parallel to the winding axis.

2. The sample gas conditioning apparatus of claim 1 , wherein the fan, the housing and the ventilated section have a joint configuration that establishes the ambient air flow through the chamber with a flow that prevents or significantly retards formation of a skin of dry gas around an outer surface of the ventilated section.

3. The sample gas conditioning apparatus of claim 2 , wherein the sample gas tube has an input end and an output end, wherein the ventilated section provides a passage for a sample gas, the passage having a passage length, wherein the passage length in combination with a flow rate of the sample gas provides, for at least a range of humidity level at the input end that is outside of a desired range, a humidity of the sample gas at the output end that is within the desired range.

4. The sample gas conditioning apparatus of claim 3 , wherein the desired range extends from approximately 15% relative humidity to approximately 90% relative humidity.

5. The sample gas conditioning apparatus of claim 1 , wherein the sample gas tube has an input and an output, wherein the sample gas conditioning apparatus further comprises a connection of the input to a conduit, wherein the conduit is configured to deliver a mixture of a mixture gas and a therapeutic gas to a patient, and wherein the sample gas tube is configured to provide passage of a sample of the mixture of the mixture gas and the therapeutic gas to the ventilated section, and to output, at the output, a humidity conditioned sample of the mixture of the mixture gas and the therapeutic gas, wherein the therapeutic gas comprises nitric oxide.

6. The sample gas conditioning apparatus of claim 1 , wherein the water permeable material comprises a sulfonated tetrafluoroethylene based fluoropolymer-copolymer.

7. The sample gas conditioning apparatus of claim 1 , wherein the water permeable material comprises Nafion.

8. The sample gas conditioning apparatus of claim 1 , wherein the ventilated section provides a ventilated tubular membrane formed of the water permeable material, and the water permeable material transfers humidity through the ventilated tubular membrane, based on First Order Kinetic reaction.

9. The sample gas conditioning apparatus of claim 8 , wherein the ventilated tubular membrane has a start and an end, and provides a passage length from the start to the end, wherein based at least in part on the passage length the ventilated tubular membrane provides, for at least a range of humidity level of a sample gas at the start that is outside of a given acceptable range, a humidity level of the sample gas at the end that is within the given acceptable range.

10. The sample gas conditioning apparatus of claim 1 , wherein the coiled tube section consists of at least two coil turns.

11. The sample gas conditioning apparatus of claim 1 , wherein the coil is a coil winding among a plurality of coil windings.

12. The sample gas conditioning apparatus of claim 1 , wherein the coil winding forms a coil winding outer surface, the coil winding outer surface being radially distal from the winding axis, wherein the chamber is defined, at least in part, by an inner surface of the housing that extends a length along the winding axis and, circumferentially around the winding axis, faces toward the winding axis.

13. The sample gas conditioning apparatus of claim 1 , wherein the winding support is configured to support the coil winding in a winding configuration having a winding radius, the winding radius extending radially from the winding axis.

14. The sample gas conditioning apparatus of claim 13 , wherein an inner surface of the housing side walls faces toward the winding axis, circumferentially around the winding axis, wherein the inner surface of the housing side walls and the winding radius define an annular volume within the chamber, centered around the winding axis, that extends from the annular end plate toward the housing open end.

15. The sample gas conditioning apparatus of claim 14 , wherein the winding support comprises a hollow structure, having longitudinal slots, configured to provide for ingress of the ambient air into the annular volume.

16. A sample gas conditioning system comprising:

a housing, at least partially defining a chamber, and at least partially defining an air input path into the chamber and an air egress path from the chamber;

a fan, connected to the housing, configured to urge an ambient air flow through the chamber, the ambient air flow entering through the air input path into the chamber, and exiting the chamber through the air egress path; and

a sample gas tube, having a section that comprises a permeable material, at least a portion of the section being arranged in the chamber as a ventilated section, the ventilated section being ventilated by the ambient air flow through the chamber and including a coiled tube section comprising a coil winding around a winding axis,

wherein the housing includes a housing cap, having a cap perimeter, and includes housing side walls that extend from the cap perimeter to a housing open end, parallel to the winding axis, wherein an inner surface of the housing side walls faces and has a clearance from an outer surface of the coil winding, wherein the housing open end has a housing open end area, wherein the air egress path includes at least a portion of the housing open end area.

17. The sample gas conditioning system of claim 16 , wherein the housing cap is a vented housing cap, providing a vent into the chamber, wherein the air input path comprises the vent.

18. The sample gas conditioning system of claim 16 , wherein the fan comprises an electric motor, supported in a fan housing, having a rotor shaft and a rotary fan blade attached to the rotor shaft,

wherein the housing includes a housing mounting flange at the housing open end, and

wherein the fan housing is secured to the housing mounting flange, in a configuration wherein the rotor shaft is parallel to the winding axis.

19. The sample gas conditioning system of claim 18 , wherein the fan housing is secured to the housing mounting flange by an adapter plate, the adapter plate having an adapter plate first face and, opposite and parallel to the adapter plate first face, an adapter plate second face, wherein the fan housing is secured, by fan housing mount bolts, to the adapter plate first face, wherein the housing mounting flange is secured, by housing mount bolts, to the adapter plate second face.

Assignments (16)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 72331 FRAME 1. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 075021/0204 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 73375 FRAME 395. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 075021/0263 →
SECURITY INTEREST Recorded Oct 28, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 073375/0395 →
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
SECURITY INTEREST Recorded Aug 1, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 072331/0001 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 051231, FRAME 0961 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0811 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
RELEASE OF SECURITY INTEREST Recorded Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY); SPECGX LLC; STRATATECH CORPORATION; VTESSE LLC (F/K/A VTESSE INC.)
Reel/Frame 060389/0839 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 056433/0640 →
CHANGE OF NAME Recorded Jun 3, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
Reel/Frame 056476/0162 →
SECURITY INTEREST Recorded Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Dec 9, 2019
From: MALLINCKRODT LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT PHARMA IP TRADING D.A.C.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 051231/0961 →
Continuity (3)
Division 15459060 · Mar 15, 2017
Provisional Application 62331694 · May 4, 2016
Related Publication 20200061328A1 · Feb 27, 2020